Related Experiment Video
Updated: Jun 28, 2026
08:40
Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
Structural insights on physiological functions and pathological effects of alpha-synuclein
Marco Bisaglia1, Stefano Mammi, Luigi Bubacco
1Department of Biology, University of Padova, Via U. Bassi 58B, 35121, Padova, Italy.
Summary
Alpha-synuclein, implicated in neurodegenerative diseases like Parkinson's, exists in various structures. This review details its conformations and the environmental factors influencing its function and pathology.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Alpha-synuclein is an intrinsically disordered protein associated with neurodegenerative disorders.
- Pathological forms involve beta-sheet aggregates, linked to Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies.
Purpose of the Study:
- To review recent structural insights into alpha-synuclein conformations.
- To examine how environmental factors influence protein structure equilibria.
- To compare hypotheses on structural relevance to protein function and pathology.
Main Methods:
- Review of recent structural studies on alpha-synuclein.
- Analysis of factors influencing protein conformation.
- Comparison of functional and pathological hypotheses.
Main Results:
- Alpha-synuclein adopts diverse conformations, influenced by lipid interactions and chemical environments.
- Specific conformations and their equilibria are critical for physiological function and pathological aggregation.
- Mutant forms of alpha-synuclein exhibit distinct structural properties.
Conclusions:
- Understanding alpha-synuclein's structural plasticity is key to deciphering its role in neurodegeneration.
- Environmental factors significantly modulate alpha-synuclein's structure-function relationship.
- Further research into specific conformations may reveal therapeutic targets for related diseases.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...